FBI Notifies Crime Labs of Errors used in DNA Match Calculations Since 1999
By Spencer S. Hsu,
Washington Post
| 05. 29. 2015
Untitled Document
The FBI has notified crime labs across the country that it has discovered errors in data used by forensic scientists in thousands of cases to calculate the chances that DNA found at a crime scene matches a particular person, several people familiar with the issue said.
The bureau has said it believes the errors, which extend to 1999, are unlikely to result in dramatic changes that would affect cases. It has submitted the research findings to support that conclusion for publication in the July issue of the Journal of Forensic Sciences, the officials said.
But crime labs and lawyers said they want to know more about the problem before conceding it would not make much difference in any given case.
“The public puts so much faith in DNA testing that it makes it especially important to make those the best estimates possible,” said Wright State University statistics professor Daniel R. Krane, an expert whose work has been cited by defense attorneys. “There is no excuse for a systematic error to many thousands of calculations in such a context.”...
Related Articles
By Emma Cieslik, Ms. Magazine | 11.20.2025
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Adam Feuerstein, Stat | 11.20.2025
The Food and Drug Administration was more than likely correct to reject Biohaven Pharmaceuticals’ treatment for spinocerebellar ataxia, a rare and debilitating neurodegenerative disease. At the very least, the decision announced Tuesday night was not a surprise to anyone paying attention. Approval...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...